Aurobindo Pharma has received its second approval from Therapeutic Goods Administration, Government of Australia for the registration of Sertaline 50mg and 100mg blister pack Tablets containing Sertaline 50mg and 100mg.
The approved indications for these therapeutic products are for treatment of children (aged 6 years and above) and adolescents with obsessive compulsive disorder, major depression, obsessive compulsive disorder and panic disorder in adults and treatment of social phobia (social anxiety disorder) in adults.
|
